BioLife Solutions, Inc.
BLFS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,195,901 | $710,437 | $773,155 | $1,435,042 |
| - Cash | $95,386 | $35,407 | $19,442 | $69,870 |
| + Debt | $30,174 | $42,691 | $43,713 | $26,879 |
| Enterprise Value | $1,130,689 | $717,721 | $797,426 | $1,392,051 |
| Revenue | $82,254 | $143,271 | $76,239 | $119,156 |
| % Growth | -42.6% | 87.9% | -36% | – |
| Gross Profit | $53,671 | $46,752 | $53,822 | $37,748 |
| % Margin | 65.3% | 32.6% | 70.6% | 31.7% |
| EBITDA | $1,532 | -$45,238 | -$124,182 | -$16,654 |
| % Margin | 1.9% | -31.6% | -162.9% | -14% |
| Net Income | -$20,184 | -$66,427 | -$139,805 | -$8,908 |
| % Margin | -24.5% | -46.4% | -183.4% | -7.5% |
| EPS Diluted | -0.44 | -1.52 | -3.29 | -0.23 |
| % Growth | 71.1% | 53.8% | -1,330.4% | – |
| Operating Cash Flow | $8,431 | -$12,498 | -$8,489 | -$4,836 |
| Capital Expenditures | -$3,227 | -$6,381 | -$10,385 | -$8,385 |
| Free Cash Flow | $5,204 | -$18,879 | -$18,874 | -$13,221 |